PHARMION

Pharmion is a global biotech company that is dedicated to the hematology and oncology communities. We work in partnership with a network of scientific and clinical advisors to identify and develop products for global hematology and oncology markets. To expand each product's potential, we have established our own regulatory, development and sales and marketing organizations in the United States, Europe, and Australia, and we have developed a third-party distributor network to serve the hemato... logy and oncology markets in 20 additional countries throughout the Middle East, Asia, and Latin America. The global capabilities within our sales, marketing and distribution organization distinguishes us from other companies of a similar size. With our international network we can reach physicians and their patients in more than 30 countries. With proven development and regulatory professionals and an experienced global commercialization team, we concentrate our resources on licensing, developing, and commercializing therapeutic products for the treatment of hematology and oncology patients. Through these efforts, we seek to provide greater therapeutic options to hematologists and oncologists with the ultimate goal of extending survival and improving patients’ quality of life.
PHARMION
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
1999-01-01
Address:
Boulder, Colorado, United States
Country:
United States
Total Employee:
501+
Status:
Active
Contact:
1(720) 564-9100
Email Addresses:
[email protected]
Total Funding:
105 M USD
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
CM&D Pharma Ltd
CM&D Pharma Limited engages in the development and commercialization of products for dietary management.
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Nucleo Life Sciences
Nucleo Life Sciences is committed to assisting you in developing and marketing your products as quickly and efficiently as possible.
Current Advisors List
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2006-11-15 | Cabrellis Pharmaceuticals | Cabrellis Pharmaceuticals acquired by Pharmion | 59 M USD |
Investors List
Versant Ventures
Versant Ventures investment in Venture Round - Pharmion
New Enterprise Associates
New Enterprise Associates investment in Venture Round - Pharmion
Greenspring Associates
Greenspring Associates investment in Venture Round - Pharmion
ProQuest Investments
ProQuest Investments investment in Venture Round - Pharmion
General Electric Pension Trust
General Electric Pension Trust investment in Venture Round - Pharmion
Bay City Capital
Bay City Capital investment in Venture Round - Pharmion
Nomura International
Nomura International investment in Venture Round - Pharmion
Nomura International
Nomura International investment in Venture Round - Pharmion
HealthCap
HealthCap investment in Venture Round - Pharmion
Aberdare Ventures
Aberdare Ventures investment in Venture Round - Pharmion
More informations about "Pharmion"
Pharmion - Crunchbase Company Profile & Funding
Pharmion is a global biotech company that is dedicated to the hematology and oncology communities. We work in partnership with a network of scientific and clinical advisors to …See details»
Pharmion 2025 Company Profile: Valuation, Investors, Acquisition ...
Pharmion General Information Description. Operator of a pharmaceutical platform intended to provide drug. The company's platform engages in the acquisition, development and …See details»
Pharmion - 2025 Company Profile & Funding - Tracxn
Pharmion was acquired by Celgene in November 2007 for $2.9B. Company Details. Website: pharmion.com; Part Of: bms.com; Key Metrics. Total Funding. $40M in 2 rounds. Latest …See details»
PRESS RELEASE: Celgene to Buy Pharmion Corporation for $2.9 …
Nov 19, 2007 If the VWAP Closing Price is less than $56.15, Pharmion stockholders will receive 0.8370 Celgene shares for each share of Pharmion common stock, and if the VWAP Closing …See details»
Pharmion - Funding, Financials, Valuation & Investors - Crunchbase
Pharmion is registered under the ticker NASDAQ:PHRM . Their stock opened with $14.00 in its Nov 6, 2003 IPO. Pharmion is funded by 11 investors. Versant Ventures and New Enterprise …See details»
Pharmion - VentureRadar
Pharmion is a biopharmaceutical company focused on acquiring, developing and commercializing innovative products for the treatment of hematology and oncology patients. Pharmion has a …See details»
Pharmion Overview Global Specialty Pharmaceutical Company …
Global Leverage • Pharmion Organization: US, EU and Australia • Distributor network in 30 additional countries • Increases product licensing opportunities • Allows for regional and global …See details»
Pharmion Corporation Company Profile | Summit, NJ | Competitors ...
Find company research, competitor information, contact details & financial data for Pharmion Corporation of Summit, NJ. Get the latest business insights from Dun & Bradstreet.See details»
BioPharmaLink profile of Pharmion Corp., United States of America,
Pharmion is an international pharmaceutical company focused on commercializing products that are responsive to specialized medical marketing programs. Founded by two experienced …See details»
Pharmion - Products, Competitors, Financials, Employees, …
Pharmion. Frequently Asked Questions (FAQ) When was Pharmion founded? Pharmion was founded in 1999. Where is Pharmion's headquarters? Pharmion's headquarters is located at …See details»
Pharmion - Overview, Revenue, Employee & Similar companies
Pharmion is a global biotech company that is dedicated to the hematology and oncology communities. We work in partnership with a network of scientific and clinical advisors to …See details»
Celgene to Acquire Pharmion for $2.9 Billion in Cash and Stock
Nov 19, 2007 Celgene Corporation (Nasdaq: CELG) and Pharmion Corporation (Nasdaq: PHRM) jointly announced the signing of a definitive merger agreement pursuant to which …See details»
Pharmion-Pharmion Corporation-企业详情-InvestGO数据库 …
Dec 31, 1998 查看医药魔方InvestGO®数据库Pharmion的公司信息。Pharmion(Pharmion Corporation),公司简介:Pharmion is a global biotech company that is dedicated to the …See details»
Pharmion - Raised $40M Funding from 15 investors - Tracxn
Mar 8, 2025 List of Pharmion's institutional investors. New Enterprise Associates, located in Menlo Park (United States), made their first investment in Pharmion on Dec 03, 2001 in its …See details»
NEA_Menlo_Park
Pharmion Overview Global Specialty Pharmaceutical Company Focused on Hematology and Oncology Licensed Four Products to Date Commercial, Regulatory and Development …See details»
Pharmion - Crunchbase Company Profile & Funding
Pharmion is a supplier of skin and hair care products. New. Resources. Advanced Search. Start Free Trial ... Experience the new Crunchbase, powered by AI . Experience the new …See details»
PHARMION CORPORATION Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for PHARMION CORPORATION of Overland Park, KS. Get the latest business insights from Dun & Bradstreet.See details»
Pharmion Corp - Company Profile and News - Bloomberg Markets
Company profile page for Pharmion Corp including stock price, company news, executives, board members, and contact informationSee details»
Pharmion - Contacts, Employees, Board Members, Advisors
Pharmion engages in the acquisition, development, and commercialization of products for the treatment of hematology and oncology patients. New. Resources. ... Log In. Experience the …See details»
Pharmion lymphoma drug wins orphan drug status | Reuters
Aug 21, 2007 Pharmion Corp. <PHRM.O> and its partner MethylGene Inc. <MYG.TO> said on Tuesday that U.S. regulators had granted orphan drug status to their experimental …See details»